Inhibition of LPAR6 overcomes sorafenib resistance by switching glycolysis into oxidative phosphorylation in hepatocellular carcinoma
Davide Gnocchi, Agata Kurzyk, Antonella Mintrone, Giovanni Lentini, Carlo Sabbà, Antonio Mazzocca
Topics & Concepts
SorafenibHepatocellular carcinomaRegorafenibCancer researchGlycolysisPharmacologyOxidative phosphorylationChemistryBiologyMedicineMetabolismBiochemistryInternal medicineCancerColorectal cancerPeroxisome Proliferator-Activated ReceptorsCancer, Hypoxia, and MetabolismSphingolipid Metabolism and Signaling